Paper39494147
CRISPR-Cas9-mediated homology-directed repair for precise gene editing.
Liao H and 4 others. Mol Ther Nucleic Acids, 2024. Cited by 123 papers, by iCite.
Cite this record
ConductScience Library. CRISPR-Cas9-mediated homology-directed repair for precise gene editing. Papers, record 39494147. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39494147
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R00 HL143194 | NHLBI NIH HHS | United States | R00HL143194 | PubMed |
Source NIH RePORTER
References221
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35580855 | ExsgRNA: reduce off-target efficiency by on-target mismatched sgRNA. | Brief Bioinform | 2022 | https://conductscience.org/library/papers/35580855 | PubMed |
| 2 | 34293323 | Seeds of their own destruction: Dominant-negative peptide screening yields functional insight and therapeutic leads. | Cell Syst | 2021 | https://conductscience.org/library/papers/34293323 | PubMed |
| 3 | 30803822 | Genome Editing with mRNA Encoding ZFN, TALEN, and Cas9. | Mol Ther | 2019 | https://conductscience.org/library/papers/30803822 | PubMed |
| 4 | 16908537 | Conservative repair of a chromosomal double-strand break by single-strand DNA through two steps of annealing. | Mol Cell Biol | 2006 | https://conductscience.org/library/papers/16908537 | PubMed |
| 5 | 28073291 | Future of rAAV Gene Therapy: Platform for RNAi, Gene Editing, and Beyond. | Hum Gene Ther | 2017 | https://conductscience.org/library/papers/28073291 | PubMed |
| 6 | 27606440 | Applications of CRISPR technologies in research and beyond. | Nat Biotechnol | 2016 | https://conductscience.org/library/papers/27606440 | PubMed |
| 7 | 30033371 | Precise and Predictable CRISPR Chromosomal Rearrangements Reveal Principles of Cas9-Mediated Nucleotide Insertion. | Mol Cell | 2018 | https://conductscience.org/library/papers/30033371 | PubMed |
| 8 | 18675941 | Comparison of nonhomologous end joining and homologous recombination in human cells. | DNA Repair (Amst) | 2008 | https://conductscience.org/library/papers/18675941 | PubMed |
| 9 | 27278775 | Global, quantitative and dynamic mapping of protein subcellular localization. | Elife | 2016 | https://conductscience.org/library/papers/27278775 | PubMed |
| 10 | 37041195 | Engineered CRISPR-OsCas12f1 and RhCas12f1 with robust activities and expanded target range for genome editing. | Nat Commun | 2023 | https://conductscience.org/library/papers/37041195 | PubMed |
| 11 | 16926856 | Mechanism of homologous recombination: mediators and helicases take on regulatory functions. | Nat Rev Mol Cell Biol | 2006 | https://conductscience.org/library/papers/16926856 | PubMed |
| 12 | 30659282 | Spatial proteomics: a powerful discovery tool for cell biology. | Nat Rev Mol Cell Biol | 2019 | https://conductscience.org/library/papers/30659282 | PubMed |
| 13 | 19941829 | PCNA is required for initiation of recombination-associated DNA synthesis by DNA polymerase delta. | Mol Cell | 2009 | https://conductscience.org/library/papers/19941829 | PubMed |
| 14 | 34107195 | CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia. | N Engl J Med | 2021 | https://conductscience.org/library/papers/34107195 | PubMed |
| 15 | 14744439 | Unraveling V(D)J recombination; insights into gene regulation. | Cell | 2004 | https://conductscience.org/library/papers/14744439 | PubMed |
| 16 | 19158789 | The promises and pitfalls of RNA-interference-based therapeutics. | Nature | 2009 | https://conductscience.org/library/papers/19158789 | PubMed |
| 17 | 27096365 | Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. | Nature | 2016 | https://conductscience.org/library/papers/27096365 | PubMed |
| 18 | 35617371 | Structural basis for RNA-guided DNA cleavage by IscB-ωRNA and mechanistic comparison with Cas9. | Science | 2022 | https://conductscience.org/library/papers/35617371 | PubMed |
| 19 | 18275380 | Mechanism of eukaryotic homologous recombination. | Annu Rev Biochem | 2008 | https://conductscience.org/library/papers/18275380 | PubMed |
| 20 | 34619744 | Transposon-associated TnpB is a programmable RNA-guided DNA endonuclease. | Nature | 2021 | https://conductscience.org/library/papers/34619744 | PubMed |
Cited by88
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 123 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42932357 | Functional impact of PCSK9 variants on LDL uptake in a knockout hepatic model. | PLoS One | 2026 | https://conductscience.org/library/papers/42932357 | PubMed |
| 42920906 | Minimal indel-inducing and window-adjustable base editing using inactive Cas12b effectors. | Mol Ther Nucleic Acids | 2026 | https://conductscience.org/library/papers/42920906 | PubMed |
| 42910966 | Toward a Local Manipulation of DNA by Quantum Fields. | J Phys Chem Lett | 2026 | https://conductscience.org/library/papers/42910966 | PubMed |
| 42899205 | Genome editing beyond transgenes: DNA-free technologies in crop improvement. | Front Plant Sci | 2026 | https://conductscience.org/library/papers/42899205 | PubMed |
| 42853350 | CRISPR-enhanced microalgae for carbon sequestration and carotenoid production: opportunities and fundamental constraints. | Bioresour Bioprocess | 2026 | https://conductscience.org/library/papers/42853350 | PubMed |
| 42852500 | Chromatin Modifications Orchestrate DNA Repair Pathway Choice: Epigenetics Strategies for Enhancing CRISPR-Cas9-Mediated Knock-In Efficiency. | Cell Prolif | 2026 | https://conductscience.org/library/papers/42852500 | PubMed |
| 42733472 | Interfering with DNA repair pathways to enhance CRISPR-Cas9-mediated homology-directed repair in a chelicerate genetic model. | iScience | 2026 | https://conductscience.org/library/papers/42733472 | PubMed |
| 42706407 | Programmable enzymes for targeted gene insertion. | Nat Rev Genet | 2026 | https://conductscience.org/library/papers/42706407 | PubMed |
| 42699102 | Targeted Nanoparticle Delivery CRISPR/Cas9: overcoming biological barriers, enhancing stability, and improving therapeutic precision. | Int J Pharm X | 2026 | https://conductscience.org/library/papers/42699102 | PubMed |
| 42681181 | Methods for Applying Prime Editing and Inverse Prime Editing in Mammalian Cell Culture. | Methods Mol Biol | 2026 | https://conductscience.org/library/papers/42681181 | PubMed |
| 42602684 | Systematic evaluation of the DNA repair machinery facilitated the development of efficient genome editing tools for the red yeast Rhodotorula toruloides. | Synth Syst Biotechnol | 2027 | https://conductscience.org/library/papers/42602684 | PubMed |
| 42584708 | CRISPR/Cas9-based repair of a heterozygous HNF1A mutation in patient-derived hiPSCs. | Hum Genet | 2026 | https://conductscience.org/library/papers/42584708 | PubMed |
| 42539480 | CRISPR/Cas9 in cancer therapy: clinical translation, mechanistic strategies, and therapeutic directions. | Front Oncol | 2026 | https://conductscience.org/library/papers/42539480 | PubMed |
| 42524609 | In vivo delivery strategies for therapeutic CRISPR genome editing. | Int J Biol Sci | 2026 | https://conductscience.org/library/papers/42524609 | PubMed |
| 42510878 | Prime Editing-Based Functional Characterization Supports a Likely Pathogenic Interpretation of NF1 c.6394T>C (p.Ser2132Pro). | Genes (Basel) | 2026 | https://conductscience.org/library/papers/42510878 | PubMed |
| 42500358 | CRISPR-SWITCH (silent mutations with intention to create heterozygotes): a strategy for monoallelic genome editing and generation of a Syt1-D365E mouse model of Baker-Gordon syndrome. | Front Genome Ed | 2026 | https://conductscience.org/library/papers/42500358 | PubMed |
| 42486986 | Efficient and precise programmable DNA knock-in without double-strand breaks. | Nature | 2026 | https://conductscience.org/library/papers/42486986 | PubMed |
| 42469498 | CRISPR-enabled functional genomics for bolstering plant tolerance to abiotic and biotic stress; a comprehensive review. | Funct Integr Genomics | 2026 | https://conductscience.org/library/papers/42469498 | PubMed |
| 42439976 | CRISPR-Cas9-based therapies for Huntington's disease and Friedreich's ataxia: mechanisms, advances, and future perspectives. | Neurogenetics | 2026 | https://conductscience.org/library/papers/42439976 | PubMed |
| 42426280 | CRISPR in clinical oncology: translational advances from molecular diagnostics to therapeutics. | Nat Rev Clin Oncol | 2026 | https://conductscience.org/library/papers/42426280 | PubMed |
Genes39
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39494147
GET https://conductscience.org/api/papers/v1/39494147/references?page=2